Literature DB >> 10380892

Integrin-mediated signaling in human neutrophil functioning.

M A Williams1, J S Solomkin.   

Abstract

Integrins are important signal transducers for virtually all neutrophil functions. Although a variety of signals ultimately result in integrin activation, the intracellular targets of integrin-initiated signals are poorly delineated to date. Polymorphonuclear (PMN) leukocyte responses to inflammation are dependent on both the stimulants and the extracellular environment encountered. Integrin ligation, by cell-cell or cell-matrix interactions, activates a variety of signaling cascades. These events dictate the nature of PMN responses to the encountered stimulus. The complex system of effector molecule recruitment and permissive signaling by integrins serves to strictly regulate PMN functions such as cell adhesion, motility, oxidant production, and protein synthesis. Moreover, there is evidence that cross-talk between integrins exists to prime integrin populations for subsequent functioning. This review summarizes the current understanding of signaling mechanisms for integrin priming and activation. In this connection, the role of specific signaling molecules in key PMN functions are examined.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10380892     DOI: 10.1002/jlb.65.6.725

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  28 in total

1.  Shear stress-induced apoptosis of adherent neutrophils: a mechanism for persistence of cardiovascular device infections.

Authors:  M S Shive; M L Salloum; J M Anderson
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

2.  Effect on polymorphonuclear cell function of a human-specific cytotoxin, intermedilysin, expressed by Streptococcus intermedius.

Authors:  M G Macey; R A Whiley; L Miller; H Nagamune
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

Review 3.  Interference of antibacterial agents with phagocyte functions: immunomodulation or "immuno-fairy tales"?

Authors:  M T Labro
Journal:  Clin Microbiol Rev       Date:  2000-10       Impact factor: 26.132

4.  Anaplasma phagocytophilum infection induces protracted neutrophil degranulation.

Authors:  Kyoung-seong Choi; Dennis J Grab; J Stephen Dumler
Journal:  Infect Immun       Date:  2004-06       Impact factor: 3.441

5.  NF-κB and STAT1 control CXCL1 and CXCL2 gene transcription.

Authors:  Susan J Burke; Danhong Lu; Tim E Sparer; Thomas Masi; Matthew R Goff; Michael D Karlstad; J Jason Collier
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-11-26       Impact factor: 4.310

6.  Myristoylated Alanine Rich C Kinase Substrate (MARCKS) is essential to β2-integrin dependent responses of equine neutrophils.

Authors:  Mary K Sheats; Kimberly C Pescosolido; Ethan M Hefner; Eui Jae Sung; Kenneth B Adler; Samuel L Jones
Journal:  Vet Immunol Immunopathol       Date:  2014-05-02       Impact factor: 2.046

7.  Membrane ruffles capture C3bi-opsonized particles in activated macrophages.

Authors:  Prerna C Patel; Rene E Harrison
Journal:  Mol Biol Cell       Date:  2008-09-03       Impact factor: 4.138

8.  The small Rho GTPase Cdc42 regulates neutrophil polarity via CD11b integrin signaling.

Authors:  Kathleen Szczur; Yi Zheng; Marie-Dominique Filippi
Journal:  Blood       Date:  2009-09-14       Impact factor: 22.113

9.  Focal adhesion kinase regulates pathogen-killing capability and life span of neutrophils via mediating both adhesion-dependent and -independent cellular signals.

Authors:  Anongnard Kasorn; Pilar Alcaide; Yonghui Jia; Kulandayan K Subramanian; Bara Sarraj; Yitang Li; Fabien Loison; Hidenori Hattori; Leslie E Silberstein; William F Luscinskas; Hongbo R Luo
Journal:  J Immunol       Date:  2009-06-26       Impact factor: 5.422

10.  Pharmacological analysis for mechanisms of GPI-80 release from tumour necrosis factor-alpha-stimulated human neutrophils.

Authors:  Takeaki Nitto; Yoshihiko Araki; Yuji Takeda; Fujiro Sendo
Journal:  Br J Pharmacol       Date:  2002-10       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.